Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • Digi-Moms: Studying blood sugar levels and physical activity patterns in individuals with gestational diabetes

    In this study, we plan to conduct a prospective exploratory study in 40 participants with gestational diabetes to examine the feasibility of collecting data with ...

    View Details

  • A Phase 1b/2 Randomized Open-Label Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy in Patients With Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer

    The goal of the study is to find out if a new drug called LBL-007, given in combination with other drugs called tislelizumab, bevacizumab, and ...

    View Details

  • EVALUATION OF FREQUENCY ALLOCATION TABLES FOR RECENTLY IMPLANTED SINGLE-SIDED DEAF COCHLEAR IMPLANT USERS

    This observational study will examine cochlear implant (CI) patients with single-sided deafness (SSD) who receive non-default frequency allocation tables (FATs) after initial stimulation to determine ...

    View Details

  • The effects of Gender-Affirming Hormone Therapy on ambulatory blood pressure of transgender adolescents

    The goal of this study is to inform regarding effects of GAHT on blood pressure, to help improve clinical practice guidelines regarding screening and treatment ...

    View Details

  • INHALE-1: A 26-week Primary Treatment Phase with 26-week Extension Open-label Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza Versus Rapid-acting Insulin Analog Injections Both in Combination with a Basal Insulin in Pediatric

    The purpose of this study is to find out whether an inhaled, ultra-rapid-acting insulin (Afrezza) works as well as rapid-acting injections. The possible benefits of ...

    View Details

  • A Phase II Study of the Interleukin-6 Receptor Inhibitor Sarilumab in Combination with Ipilimumab Nivolumab and Relatlimab in Patients with Unresectable Stage III or Stage IV Melanoma

    This study is looking at a treatment for advanced melanoma, a type of skin cancer. The study has two parts. First, patients will get a ...

    View Details

  • Distal Ischemic Stroke Treatment with Adjustable Low-profile Stentriever

    Stroke is a condition where the blood flow to the brain is blocked, potentially resulting in lack of oxygen, brain damage and loss of function ...

    View Details

  • Harvest Share: Our Communities Our Foods

    The purpose of this study is to improve diet and the social and built environments for English, Chinese, Spanish, and Bangla-speaking communities in Sunset Park ...

    View Details